论文部分内容阅读
目的研究分析孟鲁司特钠与酮替酚治疗小儿咳嗽变异性哮喘的临床疗效。方法选取2011年8月至2013年8月我院收治小儿咳嗽变异性哮喘患者40例,随机将患者分为观察组与对照组,每组20例。观察组给予孟鲁司特钠治疗,对照组给予酮替酚治疗,观察并比较两组患者治疗后临床并发症、药物使用情况及复发率。结果两组治疗后临床有效率比较,观察组显著优于对照组,(P<0.05)差异具有统计学意义。结论采取孟鲁司特钠治疗小儿咳嗽变异性哮喘,临床并发症少且疗效显著,值得临床广泛推广及应用。
Objective To study the clinical efficacy of montelukast sodium and ketotitol in the treatment of pediatric cough variant asthma. Methods From August 2011 to August 2013, 40 children with cough variant asthma were admitted to our hospital. Patients were randomly divided into observation group and control group with 20 cases in each group. The observation group was given montelukast sodium, while the control group was given ketotifen. The clinical complication, drug use and recurrence rate of the two groups were observed and compared. Results After treatment, the clinical efficiency of the two groups was significantly better than that of the control group (P <0.05), and the difference was statistically significant. Conclusion Montelukast sodium treatment of pediatric cough variant asthma, less clinical complications and significant effect, it is widely used in clinical promotion.